Abstract: The abnormal accumulation of methylmalonic acid (MMA), the leading cause of methylmalonic acidemia, can cause irreversible damage to the brain, kidney, and cardiovascular system. In addition, the accumulation of MMA in the blood has recently been associated with the occurrence of cancer, restricted bodily movement, and growth retardation. In this review, recent studies on the relationship between the metabolic abnormality of MMA and disease occurrence were summarized, concerning the brain, kidney, cardiovascular system, cancer, and skeletal muscles. It provides a theoretical basis and reference for further research and the treatment of MMA-related pathophysiological changes.

甲基丙二酸生物学功能和分子机制的研究进展

[1]AndradeVM, dal PontHS, LeffaDD, et al., 2014. Methylmalonic acid administration induces DNA damage in rat brain and kidney. Mol Cell Biochem, 391:137-145.

[2]ArbabM, MatuszekZ, KrayKM, et al., 2023. Base editing rescue of spinal muscular atrophy in cells and in mice. Science, 380(6642):eadg6518.

[3]AtkuriKR, CowanTM, KwanT, et al., 2009. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci USA, 106(10):3941-3945.

[4]BaumgartnerMR, HörsterF, Dionisi-ViciC, et al., 2014. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis, 9:130.

[5]Bednarska-MakarukM, GrabanA, Sobczyńska-MaleforaA, et al., 2016. Homocysteine metabolism and the associations of global DNA methylation with selected gene polymorphisms and nutritional factors in patients with dementia. Exp Gerontol, 81:83-91.

[6]BrismarJ, OzandPT, 1994. CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR Am J Neuroradiol, 15(8):1459-1473.

[7]BrusqueAM, RottaL, PettenuzzoLF, et al., 2001. Chronic postnatal administration of methylmalonic acid provokes a decrease of myelin content and ganglioside N-acetylneuraminic acid concentration in cerebrum of young rats. Braz J Med Biol Res, 34(2):227-231.

[8]ChandlerRJ, SloanJ, FuH, et al., 2007. Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet, 8:64.

[9]ChenL, LiuS, TaoYG, 2020. Regulating tumor suppressor genes: post-translational modifications. Sig Transduct Target Ther, 5:90.

[10]ChengAL, YaoR, CaoWJ, et al., 2019. The value of 1H-MRS and MRI in combined methylmalonic aciduria and homocystinuria. J Comput Assist Tomogr, 43(4):559-562.

[11]Cudré-CungHP, ZavadakovaP, do Vale-PereiraS, et al., 2016. Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria. Mol Genet Metab, 119(1-2):57-67.

[12]da CostaRT, Dos SantosMB, SilvaICS, et al., 2021. Methylmalonic acid compromises respiration and reduces the expression of differentiation markers of SH-SY5Y human neuroblastoma cells. ACS Chem Neurosci, 12(14):2608-2618.

[13]de KeyzerY, ValayannopoulosV, BenoistJF, et al., 2009. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res, 66:91-95.

[14]DelgadoJA, GarcíaMIP, JiménezNM, et al., 2023. Functional vitamin B12 deficiency: improving methylmalonic acid reference intervals in urine. Clin Chim Acta, 544:117334.

[15]DharI, LysneV, UlvikA, et al., 2023. Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: a prospective 2-cohort study. J Intern Med, 293(4):508-519.

[16]DilberB, Eyüboğluİ, 2022. Cranial magnetic resonance imaging findings in hypotonic infants with cobalamin deficiency and combined methylmalonic aciduria and homocystinuria. Klin Padiatr, 234(2):105-112.

[17]el HasbaouiB, MebroukN, SaghirS, et al., 2021. Vitamin B12 deficiency: case report and review of literature. Pan Afr Med J, 38:237.

[18]FigtreeGA, AdamsonPD, AntoniadesC, et al., 2022. Noninvasive plaque imaging to accelerate coronary artery disease drug development. Circulation, 146(22):1712-1727.

[19]FilomeniG, de ZioD, CecconiF, 2015. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ, 22:377-388.

[20]FornyP, SchumannA, MustedanagicM, et al., 2016. Novel mouse models of methylmalonic aciduria recapitulate phenotypic traits with a genetic dosage effect. J Biol Chem, 291(39):20563-20573.

[21]GomesAP, IlterD, LowV, et al., 2020. Age-induced accumulation of methylmalonic acid promotes tumour progression. Nature, 585:283-287.

[22]GomesAP, IlterD, LowV, et al., 2022. Altered propionate metabolism contributes to tumour progression and aggressiveness. Nat Metab, 4:435-443.

[23]GuoJC, LiuXX, WangZ, et al., 2023. Methylmalonic acid, vitamin B12, and mortality risk in patients with preexisting coronary heart disease: a prospective cohort study. Nutr J, 22:63.

[24]GuoJC, WangSJ, WanX, et al., 2024. Mitochondria-derived methylmalonic acid aggravates ischemia‒reperfusion injury by activating reactive oxygen species-dependent ferroptosis. Cell Commun Signal, 22:53.

[25]HalperinML, SchillerCM, FritzIB, 1971. The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria: a possible explantation for hypoglycemia in methylmalonic aciduria. J Clin Invest, 50(11):2276-2282.

[26]HannibalL, DiBelloPM, YuM, et al., 2011. The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans. Mol Genet Metab, 103(3):226-239.

[27]HeRX, DongH, ZhangHW, et al., 2021. Clinical and genetic studies on 76 patients with hydrocephalus caused by methylmalonic acidemia combined with homocysteinuria. Chin J Pediatr, 59(6):459-465 (in Chinese).

[28]HuCH, YeMJ, BaiJN, et al., 2023. Methylmalonic acid promotes colorectal cancer progression via activation of Wnt/β-catenin pathway mediated epithelial‒mesenchymal transition. Cancer Cell Int, 23:131.

[29]IndoHP, DavidsonM, YenHC, et al., 2007. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion, 7(1-2):106-118.

[30]KölkerS, AhlmeyerB, KrieglsteinJ, et al., 2000. Methylmalonic acid induces excitotoxic neuronal damage in vitro. J Inherit Metab Dis, 23(4):355-358.

[31]KölkerS, SauerSW, SurteesRAH, et al., 2006. The aetiology of neurological complications of organic acidaemias—a role for the blood‒brain barrier. J Inherit Metab Dis, 29(6):701-704.

[32]LashLH, 2006. Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem Biol Interact, 163(1-2):54-67.

[33]LiZC, LowV, LugaV, et al., 2022. Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. Nat Commun, 13:6239.

[34]LiuY, HuangZM, QiuHB, et al., 2024. The association between serum methylmalonic acid, cobalamin-related biomarkers, and long-term mortality risk in cancer survivors: a prospective cohort study. Am J Clin Nutr, 119(5):1122-1132.

[35]MartinelliD, DeodatoF, Dionisi-ViciC, 2011. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis, 34(1):127-135.

[36]McAuleyGE, YiuG, ChangPC, et al., 2023. Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing. Cell, 186(7):1398-1416.e23.

[37]MorathMA, OkunJG, MüllerIB, et al., 2008. Neurodegeneration and chronic renal failure in methylmalonic aciduria—a pathophysiological approach. J Inherit Metab Dis, 31(1):35-43.

[38]NielsenS, ParknerT, ArendtJFH, 2022. Vitamin B12 deficiency: correction of P-methylmalonic acid for estimated glomerular filtration rate to improve diagnostic value ‒ a confirmatory study. Scand J Clin Lab Invest, 82(4):323-328.

[39]OkunJG, HörsterF, FarkasLM, et al., 2002. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem, 277(17):14674-14680.

[40]ØstergaardE, WibrandF, ØrngreenMC, et al., 2005. Impaired energy metabolism and abnormal muscle histology in mut^- methylmalonic aciduria. Neurology, 65(6):931-933.

[41]PannérecA, MigliavaccaE, de CastroA, et al., 2018. Vitamin B12 deficiency and impaired expression of amnionless during aging. J Cachexia Sarcopenia Muscle, 9:41-52.

[42]PascoeMC, LindenT, 2016. Folate and MMA predict cognitive impairment in elderly stroke survivors: a cross sectional study. Psychiat Res, 243:49-52.

[43]PolytarchouK, DimitroglouY, VarvarousisD, et al., 2020. Methylmalonic acid and vitamin B12 in patients with heart failure. Hell J Cardiol, 61(5):330-337.

[44]ProctorEC, TurtonN, BoanEJ, et al., 2020. The effect of methylmalonic acid treatment on human neuronal cell coenzyme Q₁₀ status and mitochondrial function. Int J Mol Sci, 21(23):9137.

[45]RefsumH, SmithAD, 2003. Low vitamin B-12 status in confirmed Alzheimer’s disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry, 74(7):959-961.

[46]RibesA, VilasecaMA, BrionesP, et al., 1984. Methylmalonic aciduria with homocystinuria. In: Addison GM, Chalmers RA, Divry P, et al. (Eds.), Organic Acidurias. Springer, Dordrecht, p.129-130.

[47]RosenbergLE, LilljeqvistAC, HsiaYE, 1968. Methylmalonic aciduria—an inborn error leading to metabolic acidosis, long-chain ketonuria and intermittent hyperglycinemia. N Engl J Med, 278(24):1319-1322.

[48]RossiA, CeroneR, BiancheriR, et al., 2001. Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. AJNR Am J Neuroradiol, 22(3):554-563.

[49]SantamaríaG, NaudeN, BennettI, et al., 2023. In vivo assignment of methylmalonic acid in breast tissue using 2D MRS and relationship with breast density, menopausal status and cancer risk. NMR Biomed, 36(3):e4851.

[50]SerotJM, BarbéF, ArningE, et al., 2005. Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer’s disease. J Neurol Neurosurg Psychiatry, 76(11):1585-1587.

[51]ShuF, XiaoH, LiQN, et al., 2023. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Signal Transduct Target Ther, 8:32.

[52]SinghNP, McCoyMT, TiceRR, et al., 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res, 175:184-191.

[53]SmithAD, RefsumH, 2009. Vitamin B-12 and cognition in the elderly. Am J Clin Nutr, 89(2):707S-711S.

[54]SouzaDG, AlmeidaRF, SouzaDO, et al., 2019. The astrocyte biochemistry. Semin Cell Dev Biol, 95:142-150.

[55]SteinJ, GeiselJ, ObeidR, 2021. Association between neuropathy and B-vitamins: a systematic review and meta-analysis. Eur J Neurol, 28(6):2054-2064.

[56]StepienKM, HeatonR, RankinS, et al., 2017. Evidence of oxidative stress and secondary mitochondrial dysfunction in metabolic and non-metabolic disorders. J Clin Med, 6(7):71.

[57]Takahashi-IñiguezT, García-HernandezE, Arreguín-EspinosaR, et al., 2012. Role of vitamin B₁₂ on methylmalonyl-CoA mutase activity. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 13(6):423-437.

[58]TangF, QiuHB, LiuY, et al., 2024. Decreased cobalamin sensitivity and biological aging acceleration in the general population. J Nutr Health Aging, 28(7):100262.

[59]TejeroJ, LazureF, GomesAP, 2024. Methylmalonic acid in aging and disease. Trends Endocrinol Metab, 35(3):188-200.

[60]VermorkenAJM, ZhuJJ, HolvoetP, et al., 2021. The marker of cobalamin deficiency, plasma methylmalonic acid, may help identifying lysosomal iron trapping in patients. Its possible utility for heart failure. Redox Biol, 44:102011.

[61]ViegasCM, ZanattaÂ, GringsM, et al., 2014. Disruption of redox homeostasis and brain damage caused in vivo by methylmalonic acid and ammonia in cerebral cortex and striatum of developing rats. Free Radic Res, 48(6):659-669.

[62]WajnerM, CoelhoJC, 1997. Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production. J Inherit Metab Dis, 20(6):761-768.

[63]WangJ, TangYL, LiuY, et al., 2022. Correlations between circulating methylmalonic acid levels and all-cause and cause-specific mortality among patients with diabetes. Front Nutr, 9:974938.

[64]WangSJ, LiuYG, LiuJX, et al., 2020. Mitochondria-derived methylmalonic acid, a surrogate biomarker of mitochondrial dysfunction and oxidative stress, predicts all-cause and cardiovascular mortality in the general population. Redox Biol, 37:101741.

[65]WangXY, LiWD, XiangMX, 2022. Increased serum methylmalonic acid levels were associated with the presence of cardiovascular diseases. Front Cardiovasc Med, 9:966543.

[66]WangYX, ChristopherBA, WilsonKA, et al., 2018. Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine. Am J Physiol Endocrinol Metab, 315(4):E622-E633.

[67]WuQ, HatseS, KenisC, et al., 2024. Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty. Geroscience, 46(2):1489-1498.

[68]YangLF, GuoB, LiX, et al., 2020. Brain MRI features of methylmalonic acidemia in children: the relationship between neuropsychological scores and MRI findings. Sci Rep, 10:13099.

[69]YuanYJ, MaY, WuQ, et al., 2024. Clinical and electroencephalogram characteristics of methylmalonic acidemia with MMACHC and MUT gene mutations. BMC Pediatr, 24:119.

[70]ZhuX, TangY, CheangI, et al., 2023. Nonlinear associations of serum cobalamin with risk of all-cause and cardiovascular mortality in hypertensive adults. Hypertens Res, 46(5):1276-1286.

[71]ZsengellérZK, AljinovicN, TeotLA, et al., 2014. Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney. Pediatr Nephrol, 29(11):2139-2146.